e-learning
resources
Stockholm 2002
Sunday 15.09.2002
Thoracic oncology: clinical management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Long term survival after resection for non small cell lung cancer significance of hormonal receptors
T. N. Kontakiotis, A. Paapazoglou, O. Antonoglou, P. Spyrou, M. Christoforidis, L. Sakas, T. Kostandinidis, D. Papakosta, K. Zarogoulidis, D. Patakas (Thessaloniki, Greece)
Source:
Annual Congress 2002 - Thoracic oncology: clinical management
Session:
Thoracic oncology: clinical management
Session type:
Poster Discussion
Number:
1181
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. N. Kontakiotis, A. Paapazoglou, O. Antonoglou, P. Spyrou, M. Christoforidis, L. Sakas, T. Kostandinidis, D. Papakosta, K. Zarogoulidis, D. Patakas (Thessaloniki, Greece). Long term survival after resection for non small cell lung cancer significance of hormonal receptors. Eur Respir J 2002; 20: Suppl. 38, 1181
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Determinants of relapse and survival in completely ressected non small cell lung cancer
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012
Rates of treatment response and median survival in advanced non small cell lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 302s
Year: 2004
Long-term survival of the patients with advanced non small cell lung carcinomas after induction chemotherapy
Source: Eur Respir J 2005; 26: Suppl. 49, 78s
Year: 2005
Is gender a prognostic factor in long term survival non-small cell lung cancer?
Source: Eur Respir J 2002; 20: Suppl. 38, 185s
Year: 2002
Does long treatment delay affect survival in metastatic non-small cell lung cancer
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021
Gefitinib in the non small cell lung cancer treatment: contribution to prolongation and quality of survival
Source: Eur Respir J 2004; 24: Suppl. 48, 303s
Year: 2004
Survival outcomes of non small cell lung cancer (NSCLC) patients who are suitable for radical treatment at initial presentation
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011
Impact of radiotherapy on survival rates in chemotherapy treated non small cell lung cancer patients
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009
Surgical treatment of small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 172s
Year: 2005
Long-term survival after surgical resection for non-small cell lung cancer
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017
Does the lung function affect the survival time in patients with resected non-small cell lung cancer?
Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery
Year: 2007
Small cell lung cancer patients and their responses to treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 301s
Year: 2004
Non small cell lung cancer: options and outcome of treatment beyond second line
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Year: 2020
Validation and comparison of several published prognostic systems for patients with small cell lung cancer
Source: Eur Respir J 2011; 38: 657-663
Year: 2011
Quality indicators in lung cancer care-review of resection rates in early stage NSCLC (non small cell lung cancer) at King’s
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018
Survival of patients with extended small cell lung cancer depending on metastases location
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009
Staging with FDG-PET/CT influences stage-specific survival in non small cell lung cancer (NSCLC)
Source: Annual Congress 2011 - Imaging in oncology and infectious diseases
Year: 2011
Long time survival after resection for multiple primary lung cancers. A population-based study
Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept